Utama › Kanser (semua jenis) › Virginia › Arlington
Kajian klinikal Kanser (semua jenis) di Arlington, VA
48 kajian untuk Kanser (semua jenis) sedang mencari peserta di lokasi dalam dan sekitar Arlington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Mengambil pesertaFasa 1/2
- NEXT Virginia, Fairfax · 11 mi jauh
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Mengambil pesertaFasa 2
- Next Virginia /ID# 279684, Fairfax · 11 mi jauh
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Mengambil pesertaFasa 2
- Virginia Cancer Specialists ( Site 1102), Fairfax · 11 mi jauh
A Study of ASP3082 in Adults With Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi jauh
REC-7735 in Participants With Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT Virginia, Fairfax · 11 mi jauh
Registry Study for Radiation Therapy Outcomes
Mengambil pesertaKajian pemerhatian
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
A Study of PHN-012 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1
- PHN-012-001 Site, Fairfax · 11 mi jauh
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Mengambil pesertaFasa 3
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology, Fairfax · 11 mi jauh
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Mengambil pesertaFasa 3
- Inova Schar Cancer Institute Clinical Trials, Fairfax · 11 mi jauh
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Virginia Cancer Specialists - Fairfax /ID# 280710, Fairfax · 11 mi jauh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Mengambil pesertaFasa 2
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Mengambil pesertaFasa 1
- NEXT Virginia ( Site 0054), Fairfax · 11 mi jauh
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Mengambil pesertaFasa 1
- Investigational Site number: 404, Fairfax · 11 mi jauh
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Mengambil pesertaFasa 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi jauh
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology, Fairfax · 11 mi jauh
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- USO - Virginia Cancer Specialists, Fairfax · 11 mi jauh
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- NEXT Virginia, Fairfax · 11 mi jauh
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Mengambil pesertaFasa 1
- NEXT Oncology, Fairfax · 11 mi jauh
Project: Every Child for Younger Patients With Cancer
Mengambil pesertaKajian pemerhatian
- Inova Fairfax Hospital, Falls Church · 4 mi jauh
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
Mengambil pesertaFasa 1
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Mengambil pesertaFasa 2
- 522, Fairfax · 11 mi jauh
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Mengambil pesertaFasa 1
- Virginia Cancer Specialists - Fairfax /ID# 268559, Fairfax · 11 mi jauh
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Mengambil pesertaFasa 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · 11 mi jauh
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · 11 mi jauh
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi jauh
Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center
Mengambil pesertaSukarelawan sihat dialu-alukan
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Mengambil pesertaFasa 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT, Fairfax · 11 mi jauh
Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System
Mengambil peserta
- Inova Schar Cancer - Saville Cancer Screening and Prevention Center, Fairfax · 11 mi jauh
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Mengambil pesertaFasa 1
- Research Site, Fairfax · 11 mi jauh
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Mengambil pesertaFasa 2/3
- Virginia Cancer Specialists - Fairfax /ID# 275071, Fairfax · 11 mi jauh
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Virginia, Fairfax · 11 mi jauh
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Mengambil pesertaFasa 1/2
- NEXT Virginia, Fairfax · 11 mi jauh
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology - Virginia, Fairfax · 11 mi jauh
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Virginia, Fairfax · 11 mi jauh
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- NEXT Virginia, Fairfax · 11 mi jauh
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT Oncology, Fairfax · 11 mi jauh
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Virginia, Fairfax · 11 mi jauh
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Mengambil pesertaFasa 1
- NEXT Virigina, Fairfax · 11 mi jauh
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Mengambil pesertaFasa 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Mengambil pesertaFasa 1/2
- NEXT Virginia, Fairfax · 11 mi jauh
A Study in Patients With Advanced Cancers
Mengambil pesertaFasa 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
Kajian Kanser (semua jenis) di bandar lain
- Houston, TX121 kajian
- New York City, NY110 kajian
- Boston, MA86 kajian
- Los Angeles, CA73 kajian
- Nashville, TN65 kajian
- Philadelphia, PA59 kajian
- Durham, NC58 kajian
- Washington, DC58 kajian
- Chicago, IL51 kajian
- Seattle, WA49 kajian
- Atlanta, GA49 kajian
- St. Louis, MO46 kajian
Kajian lain di Arlington
- Kanser Paru-paru Bukan Sel Kecil104 kajian
- Kanser Metastatik53 kajian
- Kanser Kolorektal52 kajian
- Kanser Payudara46 kajian
- Kanser Ovari46 kajian
- Kanser Paru-paru41 kajian
- Kanser Endometrium39 kajian
- Kanser Pankreas33 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher26 kajian
- Kanser Paru-paru Sel Kecil23 kajian
- Kanser Payudara Triple-Negatif20 kajian
- Kanser Perut20 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.